Facebook
Twitter
Telegram
Report an ErrorMaravai LifeSciences Holdings Financial Statements 2011-2024 | MRVI
Annual Financial Statements Maravai LifeSciences Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.01 B | 1.93 B | 3.32 B | 361 M | - | - | - | - | - | - | - | - | - |
Shares |
132 M | 132 M | 115 M | 10.4 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
7.69 | 14.7 | 28.9 | 34.8 | - | - | - | - | - | - | - | - | - |
Net Income |
-119 M | 220 M | 182 M | 89 M | -4.47 M | -4.47 M | - | - | - | - | - | - | - |
Revenue |
289 M | 883 M | 799 M | 284 M | 143 M | 124 M | - | - | - | - | - | - | - |
Cost of Revenue |
149 M | 169 M | 141 M | 79.6 M | 66.8 M | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 76.3 M | 63.1 M | - | - | - | - | - | - | - |
Operating Income |
-31.6 M | 574 M | 555 M | 120 M | 24 M | - | - | - | - | - | - | - | - |
Interest Expense |
45.9 M | 20.4 M | 30.3 M | 30.7 M | 30 M | - | - | - | - | - | - | - | - |
EBITDA |
-18.8 M | 582 M | 561 M | 125 M | 48.1 M | 38.8 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 52.3 M | 46.6 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
151 M | 129 M | 100 M | 94.2 M | 48.4 M | 41.2 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Maravai LifeSciences Holdings
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
132 M | 132 M | 132 M | 132 M | - | 132 M | 132 M | 131 M | - | 118 M | 112 M | 96.6 M | - | 254 M | 254 M | 254 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-12.1 M | -6.46 M | -6.54 M | -67 K | - | 44.5 M | 71.2 M | 66.9 M | - | 54.3 M | 49.1 M | 23.1 M | 11.4 M | 39 M | 1.42 M | 23.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
64.2 M | 66.9 M | 68.9 M | 79 M | - | 191 M | 243 M | 244 M | - | 205 M | 218 M | 148 M | - | 87.9 M | 46.9 M | 51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
38.3 M | 36.7 M | 43.3 M | 33.7 M | - | 38.2 M | 37.5 M | 40 M | - | 32 M | 37.5 M | 31.4 M | - | 19.8 M | 21.2 M | 15.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-18.9 M | -15.4 M | -11.6 M | 2.53 M | - | 117 M | 181 M | 167 M | - | 157 M | 154 M | 91.2 M | - | 45.7 M | 8.12 M | 34.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
10.9 M | 11.6 M | 7.02 M | 11.8 M | - | 3.14 M | 4.43 M | 2.66 M | - | 8.54 M | 8.51 M | 7.9 M | - | 7.09 M | 7.46 M | 7.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-14.1 M | -11.3 M | -8.8 M | 4.61 M | - | 119 M | 183 M | 169 M | - | 159 M | 157 M | 92.4 M | - | 47.4 M | 9.55 M | 36.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
40.9 M | 38.9 M | 35.4 M | 38.7 M | - | 30.8 M | 28.1 M | 33.2 M | - | 25.2 M | 24.1 M | 23.5 M | - | 20.5 M | 16 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency